SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】Cash flow
Market cap
¥573.5B
P/E ratio
16.3x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | - | - | - | - | 10,896 | 10,969 | 16,573 | 16,768 | 17,055 | 17,249 | 18,178 | 17,948 |
| Cash from operations | 26,686 | 25,386 | 22,525 | 10,843 | 42,843 | 32,894 | 39,947 | 38,808 | 46,043 | 37,147 | 72,649 | 60,928 |
| Capital expenditures | - | - | - | - | -3,984 | -5,470 | -5,824 | -4,139 | -17,344 | -17,277 | -9,319 | -6,662 |
| Cash from investing | -7,847 | -61,709 | 37,052 | -28,201 | -8,259 | -2,935 | -5,175 | -53,355 | -35,169 | -26,777 | -6,145 | -8,223 |
| Payments for dividends | - | - | - | - | -10,559 | -10,580 | -10,379 | -11,188 | -11,994 | -12,607 | -11,881 | -12,111 |
| Repurchases of common stock | - | - | - | - | -1 | -14,124 | -22 | - | -12 | -26,007 | -16,962 | -37,883 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | 567 | 1,477 | 307 | 10,000 | 15,639 | - | - |
| Repayments of term debt | - | - | - | - | -8,316 | -4,098 | -500 | -3,000 | - | -5 | -2,112 | -158 |
| Cash from financing | -7,954 | 28,960 | -24,066 | -28,657 | -17,631 | -28,107 | -12,729 | -16,685 | 5,557 | -37,220 | -34,031 | -53,307 |